Ongoing Dynamic Choice to Address HIV Treatment Interruption in Malawi

Recruiting N/A Interventional Study
HIV
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
15 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
800 (estimated)
Sponsor
University of California, Los Angeles · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Repeat and prolonged treatment interruption (TI) is common and the major threat to HIV epidemic control in eastern and southern Africa. The proposed project will test an innovative long-term dynamic choice intervention for ART clients experiencing TI in Malawi. Findings will provide essential information on how to improve sustained retention among TI client, a critical step to curbing the HIV epid…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 15 years of age or older * living with HIV; * initiated ART for the first time\>3-months ago (i.e., not a new initiate); * non-pregnant; * experienced Treatment Interuptions during their most recent ARTappointment (\>28 days late). Exclusion Criteria: * pregnant women becaus…
Contacts

Kathryn L Dovel, PhD

310-267-5844

kdovel@mednet.ucla.edu

CONTACT